BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 10680585)

  • 1. Orphanin FQ/nociceptin inhibits morphine withdrawal.
    Kotlińska J; Suder P; Legowska A; Rolka K; Silberring J
    Life Sci; 2000 Jan; 66(8):PL119-23. PubMed ID: 10680585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nociceptin(1-17) fragments and its tyrosine-substituted derivative on morphine-withdrawal signs in rats.
    Kotlinska J; Dylag T; Rafalski P; Talarek S; Kosior M; Silberring J
    Neuropeptides; 2004 Oct; 38(5):277-82. PubMed ID: 15464192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats.
    Di Giannuario A; Pieretti S; Catalani A; Loizzo A
    Neurosci Lett; 1999 Sep; 272(3):183-6. PubMed ID: 10505611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptin/orphanin FQ (N/OFQ) induces a quasi-morphine abstinence syndrome in the rat.
    Malin DH; Lake JR; Moon WD; Moy D; Montellano AL; Moy E; Campbell TD; Bell MV; Bryant D; Harrison LM; Grandy DK
    Psychopharmacology (Berl); 2000 Sep; 151(4):344-50. PubMed ID: 11026741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE; Farrier DE; Wilson SG; Mogil JS
    Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
    Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.
    Chen X; McClatchy DB; Geller EB; Liu-Chen L; Tallarida RJ; Adler MW
    Brain Res; 2001 Jun; 904(2):252-8. PubMed ID: 11406123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
    Fdez Espejo E; Cador M; Stinus L
    Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test.
    Erb K; Liebel JT; Tegeder I; Zeilhofer HU; Brune K; Geisslinger G
    Neuroreport; 1997 May; 8(8):1967-70. PubMed ID: 9223086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats.
    Pomonis JD; Billington CJ; Levine AS
    Neuroreport; 1996 Dec; 8(1):369-71. PubMed ID: 9051812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orphanin FQ (nociceptin) modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli, and blocks the substance P-induced facilitation of N-methyl-D-aspartate-evoked responses.
    Wang XM; Zhang KM; Long LO; Mokha SS
    Neuroscience; 1999; 93(2):703-12. PubMed ID: 10465454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain.
    Courteix C; Coudoré-Civiale MA; Privat AM; Pélissier T; Eschalier A; Fialip J
    Pain; 2004 Jul; 110(1-2):236-45. PubMed ID: 15275773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
    Lee H
    Yonsei Med J; 2013 May; 54(3):763-71. PubMed ID: 23549827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
    Pinelli A; Trivulzio S
    J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
    Lutfy K; Maidment NT
    Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice.
    Kest B; Hopkins E; Palmese CA; Chen ZP; Mogil JS; Pintar JE
    Neuroscience; 2001; 104(1):217-22. PubMed ID: 11311544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative opioid withdrawal signs in rats: effects exerted by clothiapine administration.
    Pinelli A; Trivulzio S; Ciapponi PM
    Fundam Clin Pharmacol; 1997; 11(4):346-55. PubMed ID: 9263765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.